Anavex Life Sciences
AVXL
141 hedge funds and large institutions have $113M invested in Anavex Life Sciences in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 43 increasing their positions, 42 reducing their positions, and 26 closing their positions.
22% more call options, than puts
Call options by funds: $4.18M | Put options by funds: $3.44M
2% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 42
4% less funds holding
Funds holding: 147 → 141 (-6)
7.1% less ownership
Funds ownership: 38.81% → 31.71% (-7.1%)
19% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 26
30% less capital invested
Capital invested by funds: $161M → $113M (-$47.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Advisers
New York
|
+$2.36M |
| 2 |
Two Sigma Investments
New York
|
+$1.93M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$1.81M |
| 4 |
Renaissance Technologies
New York
|
+$1.56M |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$809K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$14.4M |
| 2 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
-$4.1M |
| 3 |
NL
NWAM LLC
Mercer Island,
Washington
|
-$3.21M |
| 4 |
Citigroup
New York
|
-$2.1M |
| 5 |
Rafferty Asset Management
New York
|
-$1.8M |
AVXL Hedge Fund Activity: Q2 2024 in Review
141 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q2 2024, worth a combined $113M — down 30% from $161M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of AVXL and 21 opened new positions — a net loss of 5 holders — while 42 trimmed existing stakes and 43 added.
The largest buyer was Two Sigma Advisers, adding an estimated $2.36M. The largest seller was State Street, cutting an estimated $14.4M.
- 141 institutional investors held Anavex Life Sciences (AVXL) as of Q2 2024, down from 147 in Q1 2024.
- Funds reported $113M of Anavex Life Sciences stock for Q2 2024, down 30% quarter-over-quarter.
- 21 funds opened new Anavex Life Sciences positions in Q2 2024 and 26 closed out, a net change of -5 holders.
- The largest Anavex Life Sciences buyer in Q2 2024 was Two Sigma Advisers, an estimated $2.36M added.
- The largest Anavex Life Sciences seller in Q2 2024 was State Street, an estimated $14.4M sold.
Based on aggregated 13F filings for Q2 2024.